Biomerica: In The Current Report On Form 8k Filed On December 9, 2022 (the Original 8k ) By Biomerica, Inc. (the Company ). The Original 8k Reported The Results Of The Stockholder Vote On Matters Submitted To A Vote At The Company S 2022 Annual Meeting (the 2022 Annual Meeting ) Of Stockholders Of The Company Held On December 7, 2022, At Its Corporate Headquarters In Irvine, California. The Original 8k Reported That Proposal 5 To Ratify And Approve The Company S 2022 Stock Incentive Plan ( Proposal 5 ), Was Approved At The 2022 Annual Meeting, Based On The Company S Application Of A Voting Standard Requiring The Affirmative Vote Of The Majority Of Shares Present In Person Or By Proxy At The Meeting And Who Voted For, Against Or Abstained On The Subject Matter, But Excluded Broker Nonvotes. The Voting Standard The Company Applied Was Incorrect. Pursuant To The Company S Amended And Restated Bylaws, The Correct Voting Standard For Proposal 5 Required The Affirmative Vote Of The Majority Of Shares Present In Person Or By Proxy At Such Meeting And Entitled To Vote At The Meeting

Show full article

This functionality is available for registred users only

• Full name
  Biomerica, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***